sj-pdf-1-tam-10.1177_17588359211012361 – Supplemental material for Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice

Autor:	Brückl, Wolfgang M., Reck, Martin, Griesinger, Frank, Schäfer, Harald, Kortsik, Cornelius, Gaska, Tobias, Rawluk, Justyna, Krüger, Stefan, Kokowski, Konrad, Budweiser, Stephan, Ficker, Joachim H., Hoffmann, Christopher, Schüler, Andrea, Laack, Eckart
Rok vydání:	2021
Předmět:	110203 Respiratory Diseases FOS: Clinical medicine 111702 Aged Health Care FOS: Health sciences 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified 111299 Oncology and Carcinogenesis not elsewhere classified
ISSN:	1758-8359
DOI:	10.25384/sage.14565286.v1
Popis:	Supplemental material, sj-pdf-1-tam-10.1177_17588359211012361 for Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice by Wolfgang M. Brückl, Martin Reck, Frank Griesinger, Harald Schäfer, Cornelius Kortsik, Tobias Gaska, Justyna Rawluk, Stefan Krüger, Konrad Kokowski, Stephan Budweiser, Joachim H. Ficker, Christopher Hoffmann, Andrea Schüler and Eckart Laack in Therapeutic Advances in Medical Oncology
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5fbc5697f8be94cdc5c0447d3ef6f4cc Zobrazit plný text záznamu